In a Japanese cohort, 6.9% of children with biallelic GJB2 variants passed the newborn hearing screen but developed HL later, underscoring the need for continued audiologic surveillance and genetic follow-up after newborn screening [99]. This evidence concerns the gene GJB2 and Hodgkins lymphoma.